The takeover deliberations come shortly after Grifols completed the sale of its 20% stake in Chinese blood products unit Shanghai RAAS to Haier, a deal first announced in 2020, raising cash of ...

Spanish drugmaker Grifols has hit back at hedge fund Gotham ... of its interests in Chinese blood products unit Shanghai RAAS to Haier, a deal first announced in 2020. The drugmaker has been ...

Grifols (GRFS) issued a statement to address certain information published in a media outlet on March 8, specifically a front-page article titled “The CNMV reveals to the judge ‘continuous ...

In response, Grifols, a global leader in plasma science and the production of plasma-derived medicines, has embarked on a groundbreaking program in partnership with The Michael J. Fox Foundation ...

In this article, we are going to take a look at where Grifols, S.A. (NASDAQ:GRFS) stands against the other pharma stocks. The Rising Demand for Weight-Loss Medications and GLP-1 Developments ...

April 10, 2024 Grifols to refinance debt due in 2025 via sales of notes, Shanghai RAAS stake Spanish drug maker Grifols plans to meet its debt payments in 2025 with the proceeds of new senior ...

(Bloomberg) -- Brookfield Asset Management is awaiting information from Grifols SA about related-party transactions as it seeks to complete its due diligence on the business, according to a person ...